Home/Filings/4/0001209191-23-023684
4//SEC Filing

Yao Zhengbin 4

Accession 0001209191-23-023684

CIK 0001538210other

Filed

Apr 5, 8:00 PM ET

Accepted

Apr 6, 8:37 PM ET

Size

17.2 KB

Accession

0001209191-23-023684

Insider Transaction Report

Form 4
Period: 2023-04-04
Yao Zhengbin
Director
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2023-04-0461,6780 total
    Exercise: $1.82Exp: 2032-06-12Common Stock (61,678 underlying)
  • Award

    Stock Option (right to buy)

    2023-04-04+61,67861,678 total
    Exercise: $1.64Exp: 2032-06-12Common Stock (61,678 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2023-04-049,5560 total
    Exercise: $17.00Exp: 2031-02-10Common Stock (9,556 underlying)
  • Award

    Stock Option (right to buy)

    2023-04-04+9,5569,556 total
    Exercise: $1.64Exp: 2031-02-10Common Stock (9,556 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2023-04-0423,1220 total
    Exercise: $4.31Exp: 2018-03-18Common Stock (23,122 underlying)
  • Award

    Stock Option (right to buy)

    2023-04-04+23,12223,122 total
    Exercise: $1.64Exp: 2018-03-18Common Stock (23,122 underlying)
Footnotes (3)
  • [F1]The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on June 13, 2022, of which all of the shares subject to such option will vest on June 13, 2023, subject to Mr. Yao's continued service on such vesting date.
  • [F2]The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 11, 2021, of which all of the shares subject to such option have vested.
  • [F3]The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 19, 2019, of which all of the shares subject to such option have vested.

Issuer

NexImmune, Inc.

CIK 0001538210

Entity typeother

Related Parties

1
  • filerCIK 0001326228

Filing Metadata

Form type
4
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 8:37 PM ET
Size
17.2 KB